Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Artemis 2 captures historic 'Earthset' photo | Space photo of the day for April 7, 2026 - 2Which Startup's Innovation Could Reform Medical care?
- 3AfD in Brandenburg takes back suit against the intelligence service
- 4Israel's ban on unsupervised reporters in Gaza causes strategic harm to legitimacy
- 5Between 600 to 800 aid trucks entering Gaza daily since start of ceasefire, COGAT confirms
- The 15 Most Rousing TED Chats on Self-awareness
- Ukrainian man arrested in Germany on suspicion of spying for Russia
- Fossils from China show complex life evolved millions of years earlier than once thought
- The most effective method to Decide the Best Auto Crash Attorney for Your Lawful Necessities
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- The wolf supermoon will kick off 2026 with a celestial bang. Here's when and how to see it.
- The Electric Toyota Hilux Is Finally here, But It's Not Cheap
- Putting pig organs in people is OK in the US, but growing human organs in pigs is not – why is that?
- The Solution to Flexibility: Developing Internal Fortitude Notwithstanding Misfortune
